| First Author | Zhao H | Year | 2021 |
| Journal | Theranostics | Volume | 11 |
| Issue | 15 | Pages | 7600-7615 |
| PubMed ID | 34158869 | Mgi Jnum | J:321346 |
| Mgi Id | MGI:6740727 | Doi | 10.7150/thno.47845 |
| Citation | Zhao H, et al. (2021) Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p. Theranostics 11(15):7600-7615 |
| abstractText | Rationale: Cardiac fibrosis is an important feature of cardiac remodeling and is a hallmark of heart failure. Recent studies indicate that elevated IgE plays a causal role in pathological cardiac remodeling. However, the underlying mechanism of how IgE promotes cardiac fibrosis has not been fully elucidated. Methods and Results: To explore the function of IgE in cardiac fibrosis, we stimulated mouse primary cardiac fibroblasts (CFs) with IgE and found that both IgE receptor (FcepsilonR1) and fibrosis related proteins were increased after IgE stimulation. Specific deletion of FcepsilonR1 in CFs alleviated angiotensin II (Ang II)-induced cardiac fibrosis in mice. To investigate the mechanisms underlying the IgE-mediated cardiac fibrosis, deep miRNA-seq was performed. Bioinformatics and signaling pathway analysis revealed that IgE upregulated Col1a1 and Col3a1 expression in CFs by repressing miR-486a-5p, with Smad1 participating downstream of miR-486a-5p in this process. Lentivirus-mediated overexpression of miR-486a-5p was found to alleviate Ang II-induced myocardial interstitial fibrosis in mice. Moreover, miR-486-5p serum levels were lower in patients with heart failure than in healthy controls, and were negatively correlated with NT-proBNP levels. Conclusions: Our study demonstrates that elevated IgE promotes pathological cardiac fibrosis by modulating miR-486a-5p and downstream factors, such as Smad1. These findings suggest new targets for pathological cardiac fibrosis intervention. |
